Sulfatinib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sulfatinib, covering 2020-02-13 to 2020-02-13. Get the full timeline:
Most recent: Clinical Trial Update: Study of Sulfatinib in Treating Advanced Medullary Thyroid Carcinoma and Iodine-refractory Differentiated Thyroid Carcinoma [Phase 2]